|
Event Registration for Clinicians | Molecular Tumor Board: Integrating Biomarker Analyses into Clinical Decision-Making Regarding the Use of Immune Checkpoint Inhibitors in Cancer Treatment — April 3, 2017, Washington, DCThis activity is intended for medical oncologists, hematologists, surgeons, radiation oncologists, oncology nurses and other healthcare professionals involved in basic, translational and clinical cancer research or treatment. You are now registering as a practicing physician, fellow or other healthcare provider involved in the treatment of cancer. If you are not a clinician in practice, click here to register as a nonclinician. |